NCT07019727 ESSKA/ESMA ACL Injury Prevention Program in Czech Sport
| NCT ID | NCT07019727 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Masaryk University |
| Condition | Double Leg Vertical Jump (DLVJ) |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-06-12 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-06-12 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to address the rising incidence of ACL injuries, particularly among adolescents, by developing and implementing a comprehensive prevention program based on the evidence-based "ACL Prevention for ALL" framework recommended by ESSKA-ESMA. The project focuses on muscle strengthening, flexibility, coordination, proper movement techniques, and a multidisciplinary approach involving coaches, physiotherapists, and physicians. Through targeted exercise modules, education, and dynamic evaluation-including 2D motion analysis-the study seeks to reduce ACL injuries, enhance movement safety, and enable individualized training plans by identifying and correcting muscle and biomechanical imbalances.
Eligibility Criteria
Inclusion Criteria: * Age group: Participants aged 17-20 years Sports activity: Individuals actively engaged in sports with a high risk of ACL injury Health status: Participants with no or minimal previous knee joint injuries that do not limit their current physical activity Willingness to participate: Agreement to take part in the prevention program, including regular training and assessments Informed consent: Signed informed consent for participation in the program and testing procedures; for minors, consent must be signed by legal guardians Exclusion Criteria: Current injury: Individuals with a current knee joint injury requiring treatment or surgery Chronic conditions: Participants with chronic diseases or conditions that may affect the outcome of injury prevention (e.g., congenital abnormalities, neuromuscular disorders, or cardiovascular diseases) Insufficient consent: Individuals who are unable or unwilling to provide written informed consent Irregular participation: Individuals who do not comply with regular participation in the training program or assessments
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07019727 clinical trial?
This trial is open to participants of all sexes, aged 17 Years or older, up to 20 Years, studying Double Leg Vertical Jump (DLVJ). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07019727 currently recruiting?
Yes, NCT07019727 is actively recruiting participants. Contact the research team at lujc.michael@fnbrno.cz for enrollment information.
Where is the NCT07019727 trial being conducted?
This trial is being conducted at Brno, Czechia.
Who is sponsoring the NCT07019727 clinical trial?
NCT07019727 is sponsored by Masaryk University. The trial plans to enroll 100 participants.